Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Abcam completes $340m strategic acquisition and expands kit capacity and capability 2021-10-27 14:00
Antengene to Host its First R&D Days on November 16 and November 18, 2021 2021-10-25 20:00
GC Group strengthens Sustainable Growth for business and customers with "Together To Net Zero" Roadmap 2021-10-25 19:05
Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer 2021-10-25 17:00
Technological supremacy reigns in Chengdu 2021-10-22 21:14
Aero HygenX Partners with Ethiopian Airlines for Deployment of Autonomous UV-C Disinfecting Solution 2021-10-21 21:57
Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates 2021-10-21 16:00
IND Application for Phase III Clinical Study of Anti-HER2 Bispecific Antibody KN026 was Officially Accepted by CDE 2021-10-21 10:31
Singapore-based Biosyngen receives 500 million yuan in investment 2021-10-21 09:30
EVERSANA and Intouch Group join forces, adding the premiere digital-first agency network to the market leader in next generation commercialization 2021-10-20 22:34
BioVaxys Files US Patent Application for Pan-Sarbecovirus Vaccine 2021-10-20 21:24
Creatus Biosciences Inc. acquires the exclusive option to IP Assets from Stora Enso to Commercialize Xylitol Bioproduction from Biomass 2021-10-20 21:00
HistoIndex and Galecto to Collaborate on Galecto's Phase 2a MYLOX-1 Clinical Trial to Advance Myelofibrosis Assessment with AI-based Stain-free Digital Pathology 2021-10-20 18:00
Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer 2021-10-19 23:30
Excelra Announces Addition of Sudip Nandy to its Board of Directors 2021-10-19 21:00
Moët Hennessy Breaks New Ground For Innovation: The Robert-Jean De Vogüé Research Center 2021-10-19 21:00
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections 2021-10-19 09:00
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge 2021-10-19 06:51
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046 2021-10-18 10:19
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams 2021-10-18 09:00
1 98 99 100 101 102 212